What the English source shows.
- Evidence group
- In vivo animal studies
- Journal
- FREE RADIC BIOLOGY AND MEDICINE, 2018 AUG 20;124:328-341
- English PDF
- Page 102
Abstract focus
Background: Traumatic brain injury (TBI) is a major public health problem estimated to affect nearly 1.7 million people in the United States annually. Due to the often debilitating effects of TBI, novel preventative agents are highly desirable for at risk populations.
Context from Dr. Gutman’s comments
Using an animal model of mild brain trauma, Dan Linseman’s team at the University of Denver examined mice fed either Immunocal or placebo. When tested for markers of oxidative stress and other signs of brain injury, those on Immunocal showed improved glutathione levels.
How to use this study responsibly
- Read it according to its evidence group, not as a universal product promise.
- Use the English PDF to verify the abstract and commentary directly.
- For medical conditions, treatment, pregnancy, breastfeeding or medication, speak with a qualified healthcare professional.